By knowing in advance if they were stenting a hot plaque, doctors could recommend other options such as bypass surgery or drug treatment, Dr. Muller says.
To avoid that issue, Dr. Muller envisions the technology as part of a strategy in which people would first be identified as at risk through a genetic test and a noninvasive imaging test such as a CT scan before being referred for the spectroscopy analysis.